These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2242589)

  • 21. Retinoid binding to retinol-binding protein and the interference with the interaction with transthyretin.
    Malpeli G; Folli C; Berni R
    Biochim Biophys Acta; 1996 May; 1294(1):48-54. PubMed ID: 8639713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma retinol and alpha-tocopherol concentrations in insulin-dependent diabetes mellitus: their relationship to microvascular complications.
    Martinoli L; Di Felice M; Seghieri G; Ciuti M; De Giorgio LA; Fazzini A; Gori R; Anichini R; Franconi F
    Int J Vitam Nutr Res; 1993; 63(2):87-92. PubMed ID: 8407170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tubulopathy with macroalbuminuria due to diabetic nephropathy and primary glomerulonephritis.
    Yaqoob M; McClelland P; Patrick AW; Stevenson A; Mason H; Bell GM
    Kidney Int Suppl; 1994 Nov; 47():S101-4. PubMed ID: 7869656
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proteinuria and activated T-lymphocytes in diabetic nephropathy.
    Bending JJ; Lobo-Yeo A; Vergani D; Viberti GC
    Diabetes; 1988 May; 37(5):507-11. PubMed ID: 3258834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A molecular model for the retinol binding protein-transthyretin complex.
    Aqvist J; Tapia O
    J Mol Graph; 1992 Jun; 10(2):120-3, 111. PubMed ID: 1637749
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retinol-binding protein 4 as a plasma biomarker of renal dysfunction and cardiovascular disease in type 2 diabetes.
    Cabré A; Lázaro I; Girona J; Manzanares J; Marimón F; Plana N; Heras M; Masana L
    J Intern Med; 2007 Oct; 262(4):496-503. PubMed ID: 17875187
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low-molecular-weight proteinuria in insulin-dependent diabetes mellitus: a study of the urinary excretion of beta 2-microglobulin and retinol-binding protein in alkalinized patients with and without microalbuminuria.
    Watts GF; Powell M; Rowe DJ; Shaw KM
    Diabetes Res; 1989 Sep; 12(1):31-6. PubMed ID: 2698303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased plasma concentration of von Willebrand factor in insulin dependent diabetics with incipient nephropathy.
    Jensen T
    BMJ; 1989 Jan; 298(6665):27-8. PubMed ID: 2492846
    [No Abstract]   [Full Text] [Related]  

  • 29. Urinary albumin and retinol-binding protein in diabetes.
    Beetham R; Silver A; Dawnay A
    Clin Chem; 1987 May; 33(5):713. PubMed ID: 3568365
    [No Abstract]   [Full Text] [Related]  

  • 30. Hemorheology, plasma protein composition and von Willebrand factor in type I diabetic nephropathy.
    Zimmermann J; Schramm L; Wanner C; Mulzer E; Henrich HA; Langer R; Heidbreder E
    Clin Nephrol; 1996 Oct; 46(4):230-6. PubMed ID: 8905207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterisation of diabetic proteinuria.
    Myer R; Marshall W; Jones RH; Parsons V; Watkins P
    Ric Clin Lab; 1980; 10(1):143-8. PubMed ID: 7466154
    [No Abstract]   [Full Text] [Related]  

  • 32. Proteinuria in type 2 diabetic patients with renal impairment: the changing face of diabetic nephropathy.
    Packham DK; Ivory SE; Reutens AT; Wolfe R; Rohde R; Lambers Heerspink H; Dwyer JP; Atkins RC; Lewis J;
    Nephron Clin Pract; 2011; 118(4):c331-8. PubMed ID: 21293156
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of prostaglandin E1 on slight proteinuria in non-azotaemic diabetics.
    Okada S; Sato K; Higuchi T; Ichiki K; Tanokuchi S; Ishii K; Hamada H; Ota Z
    J Int Med Res; 1992 Feb; 20(1):94-7. PubMed ID: 1568524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The meaning of serum levels of advanced glycosylation end products in diabetic nephropathy.
    Shimoike T; Inoguchi T; Umeda F; Nawata H; Kawano K; Ochi H
    Metabolism; 2000 Aug; 49(8):1030-5. PubMed ID: 10954022
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation analysis of urine proteins and inflammatory cytokines with osteoporosis in patients with diabetic nephropathy.
    Zhao Z
    J Musculoskelet Neuronal Interact; 2018 Sep; 18(3):348-353. PubMed ID: 30179212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retinyl esters, retinol, retinol-binding protein and prealbumin in malnourished, xerophthamic children treated by injection of vitamin A.
    Anbunathan P; Pirie A
    Proc Nutr Soc; 1979 Sep; 38(2):71A. PubMed ID: 574274
    [No Abstract]   [Full Text] [Related]  

  • 37. High levels of circulating TNFR1 increase the risk of all-cause mortality and progression of renal disease in type 2 diabetic nephropathy.
    Fernández-Juárez G; Villacorta Perez J; Luño Fernández JL; Martinez-Martinez E; Cachofeiro V; Barrio Lucia V; Tato Ribera AM; Mendez Abreu A; Cordon A; Oliva Dominguez JA; Praga Terente M
    Nephrology (Carlton); 2017 May; 22(5):354-360. PubMed ID: 27003829
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Signaling by retinol and its serum binding protein.
    Noy N
    Prostaglandins Leukot Essent Fatty Acids; 2015 Feb; 93():3-7. PubMed ID: 25481334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Diurnal changes in blood pressure, albuminuria and urinary excretion of retinol-binding protein in type I diabetics].
    Pontuch P; Toserová E; Bulas J; Kratochvíl'ová H
    Vnitr Lek; 1996 Jan; 42(1):3-6. PubMed ID: 8629357
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mean platelet volume and related factors in patients at different stages of diabetic nephropathy: a preliminary study.
    Turgutalp K; Özhan O; Akbay E; Tombak A; Tiftik N; Ozcan T; Yilmaz S; Helvaci I; Kiykim A
    Clin Appl Thromb Hemost; 2014 Mar; 20(2):190-5. PubMed ID: 22914809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.